LULU vs XOM: Which Is the Better Buy?

Side-by-side comparison of Lululemon Athletica Inc. and Exxon Mobil Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-04.
Lululemon Athletica Inc. Β· Consumer Cyclical
$128.98
+307.7% upside to fair value
Grade C
VS
Exxon Mobil Corporation Β· Energy
$154.46
-37.3% upside to fair value
Grade C
QuantHub Verdict
LULU has more upside to fair value (+307.7%). LULU trades at a lower forward P/E (9.7x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric LULU XOM
Current Price $128.98 $154.46
Fair Value Estimate $525.85 $96.85
Upside to Fair Value +307.7% -37.3%
Market Cap $15.1B $642.0B
Forward P/E 9.7x 23.2x
EV / EBITDA 5.6x 10.3x
Price / Sales 1.4x 2.0x
Price / FCF 16.4x 27.2x
Revenue Growth YoY +0.8% -1.3%
Gross Margin 56.6% 21.7%
Operating Margin 19.8% 10.5%
Return on Equity 34.8% 11.0%
Dividend Yield 0% 0%
FCF Yield 6.09% 3.68%
Analyst Consensus Hold Buy
Investment Thesis
LULU β€” Lululemon Athletica Inc.
Lululemon Athletica Inc. is a premium athletic apparel retailer operating primarily in the consumer cyclical sector with a focus on apparel retail. The company has a strong brand and historically high profitability with a gross margin of 56.6% and ROE of 34.8%, but it faces significant near-term challenges including earnings pressure with a 21.6% decline in earnings in the most recent quarter and…
XOM β€” Exxon Mobil Corporation
Exxon Mobil Corporation operates as a global integrated oil and gas company with significant operations in upstream, energy products, chemical products, and specialty products segments. The company benefits from a highly experienced management team with decades of internal tenure, led by CEO Darren Woods. Despite strong cash flow generation and operational scale, Exxon is currently overvalued, tr…
Accumulation Zones
Metric LULU XOM
Zone Low $394.39 $72.64
Zone High $446.97 $82.32
In Buy Zone? Yes No
← LULU Research    XOM Research β†’    All Research